Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  SWAN Knowledge Base
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Pathways
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Nitric Oxide and Zinc—Conspirators in Cell Death
12 February 2004. Individually, both nitric oxide (NO) and zinc (Zn+) have been implicated in triggering neurodegeneration (see related news for NO) and Zn2+). But who would have thought that the two small molecules act in concert to activate apoptosis? That's the conclusion Stuart Lipton and colleagues propose in a report in the February 5 Neuron.

Previous work had shown that Zn2+ may spill from intracellular stores in response to increases in NO (see, for example, Cuajungco and Lees, 1998). To test if this trigger works in neurons, first author Ella Bossy-Wetzel and colleagues at the Burnham Institute and the University of California, both in La Jolla, exposed cultures of cerebrocortical neurons to S-nitrosocysteine (SNOC), a commonly used NO generator. Bossy-Wetzel found that SNOC caused more than a 10-fold increase in the amount of free zinc in the neuron, as judged by the fluorescence of the Zn2+ indicator Newport Green. Adding the extracellular metal chelator EDTA had no effect on this spike, indicating that the metal must be coming from intracellular stores, possibly metalloproteinases (see ARF related news story). Then, the scientists used a slightly more sophisticated fluorescent probe, Rhod-zin3, which has little affinity for calcium and superior kinetics (those interested in its properties could check out Sensi et al., 2003). This experiment indicated that the metal was mobilized within 10 minutes of adding SNOC, and that it was initially localized to the mitochondria. This hinted at apoptotic pathways, some of which require mitochondrial proteins.

But is any of this in-vitro work physiologically relevant? Quite possibly, argue the authors. That’s because NMDA (N-methyl-D-aspartate), an agonist of the glutamatergic receptor of the same name, mimics the effect of SNOC, and it is known that intense stimulation of the NMDA receptor activates neuronal nitric oxide synthase (nNOS), which in turn generates increased NO.

Next, Bossy-Wetzel and colleagues used a cell-free system to investigate how the zinc spike may affect the mitochondria. They found that adding even small amounts (0.1 micromolar) of the metal blocked respiration by almost 20 percent, while one micromolar zinc blocked it by 70 percent. Zinc also made the organelles swell up and release cytochrome c, a known trigger of the apoptotic pathway.

That's not all. The authors also suggest that zinc may be a prime player in NO-induced activation of p38 MAPK, a cytoplasmic kinase known as a powerful neurodegenerative trigger (see, most recently, Xie et al., 2004). When the scientists added NO to neurons in the presence of the zinc chelator TPEN, p38 remained inactive.

Overall, the results suggest that NO and zinc cooperate to deliver a double whammy to the cell. Zinc released by the gas causes mitochondrial damage, such as respiration block and cytochrome c leakage, and it activates the p38 MAPK. How the latter contributes to neurodegeneration is debated, but the authors postulated that an expulsion of monovalent ions might drive rapid shrinking of the cell. To test this hypothesis, the authors measured intracellular potassium concentrations before and after inducing cell death with NO. They found that potassium was first lost in distal neurites, then in proximal neurites and cell bodies. The process took only about 20 minutes, and blocking potassium efflux with tetraethylammonium prevented it, confirming the authors’ suspicions. When Bossy-Wetzel carried out the same experiment in neurons expressing a dominant negative form of p38, the potassium channel was unaffected and the cells maintained their volume. Thus, NO may cause cell death by a combination of respiratory stress, loss of osmotic pressure, and activation of apoptotic pathways, all mediated by the little metal ion, zinc.

Where do mitochondria intersect with these pathways? The answer may lie in the organelle’s prime function, respiration. When the respiratory chain is interrupted (as with the insecticide rotenone, a toxin used to mimic neuronal loss in Parkinson’s disease—see ARF related news story), reducing equivalents build up and respiratory chain components begin passing electrons to whatever receptor is most accessible, usually oxygen. Highly reactive oxygen species (ROS, such as superoxide and hydroxyl radicals) are thus formed. Besides inactivating essential macromolecules, ROS also convert NO to peroxynitrite, which is even more reactive than the gas itself. A theoretical chain of events, perhaps, but in support the authors found that superoxide scavengers, such as superoxide dismutase, prevent the deleterious effects of NO on neurons, including p38 and potassium channel activation. Being a respiratory chain inhibitor, zinc fits this picture. It is ironic, if not surprising, that the respiratory chain, so heavily reliant on heavy metals to shunt electrons, should be scuppered by zinc.—Tom Fagan.

Reference:
Bossy-Wetzel E, Talantov MV, Lee WD, Scholzke MN, Harop A, Mathews E, Gotz T, Han J, Ellisman MH, Perkins GA, Lipton SA. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004 February 5;41:351-365. Abstract

 
Comments on News and Primary Papers
Comment by:  Ranganath Rao
Submitted 18 February 2004 Posted 19 February 2004
  I recommend the Primary Papers

This is a very interesting finding in line with our publicaion. We have published already our finding on trace metal increase in moderately affected AD brain compared to control. In particular, we found that Zn was higher than other elements Si, Cu, Mg, Ca, Fe, Al , Fe, etc. However Fe, & Al was extremely elevated only in severe AD. Publiction is available In Alzeimr's Reports Vol 2, No. 4, 1999, pp 241-246. With regards, R.V.Rao & K.S.J.Rao et.al

View all comments by Ranganath Rao
Comments on Related News
Related News: Pink Mutations Link Parkinson’s Disease to Mitochondria

Comment by:  Mark Cookson
Submitted 15 April 2004 Posted 15 April 2004

The cloning of the gene for the PARK6 locus by Enza-Maria Valente and her colleagues now gives us a triumvirate of recessive genes that cause parkinsonism in humans; parkin, DJ-1 and now Pink1. Logically, the identification of three recessive mutations with similar phenotypes suggests that either 1) these three genes now delineate a single pathogenic pathway or 2) they point to different pathogenic processes that happen to all cause loss of a small group of neurons in the substantia nigra.

PINK1 looks very much like a serine/threonine-directed protein kinase, and thus has no immediate connection to the E3-ligase activity of parkin or the varied putative activities of DJ-1. This suggests the involvement of diverse cellular pathways. However, there are one or two intersecting observations that may indicate some similarities among these different gene products. The first is that Pink1 localizes to mitochondria. DJ-1 can localize to mitochondria under some circumstances, and a fraction of parkin is also found in this organelle. The proportion of parkin that localizes to...  Read more

View all comments by Mark Cookson


Related News: Pink Mutations Link Parkinson’s Disease to Mitochondria

Comment by:  Michael Schlossmacher, ARF Advisor
Submitted 29 April 2004 Posted 29 April 2004

The two exciting reports in ScienceExpress of two discoveries, one, the mutant Pink1 gene at the root of PARK6-linked autosomal recessive Parkinson disease; and two, the functional inactivation of parkin's ubiquitin ligase activity by S-nitrosylation, provide strong support for an integrated picture of Parkinson's disease. The characterizations of Pink1 localization (and thus, likely, function) in mitochondria and parkin's inactivation as a result of excess oxidative stress cement two cornerstones of PD pathogenesis, mitochondrial impairment and sustained oxidative stress. They also highlight the relevance of wild-type parkin in the development of sporadic, late-onset PD, given its role in regulating steady-state levels of both mitochondrial enzymes and antioxidant proteins in parkin-deficient mouse brain (see Palacino et al., 2004 in ARF related news story).

View all comments by Michael Schlossmacher

Related News: NO Laughing Matter—Nitrosylation of Isomerase Spells Trouble for Neurons

Comment by:  Veer Bala Gupta, K.S. Jagannatha Rao
Submitted 31 May 2006 Posted 9 June 2006

Amyloid-β peptides induce DNA fragmentation: an alternative pathway yet to be understood in Alzheimer disease pathology
The paper (Prestwich et al., 2005) has fascinated us and made us believe that we are in the right direction toward exploring an alternative pathway for the pathogenesis of the Alzheimer disease. Our earlier finding of amyloid-β peptides binding to and inducing conformational change in DNA (Hegde et al., 2004) led us to study the effect of amyloid-β peptides on DNA integrity. That other amyloidogenic peptides, such as α-synuclein and prion, also were found to bind to DNA (Veer Bala Gupta et al., 2006), made us argue that there is a common mechanism of action of these peptides at work in neurodegeneration. In this perspective, we highlighted an interesting mechanism of different molecular forms (monomer-oligomer aggregates) of amyloid-β and α-synuclein binding to DNA and inducing DNA damage (Hegde et al., 2004, Abstract). It also gives us insight into understanding the different events taking place at different stages of...  Read more

View all comments by Veer Bala Gupta
View all comments by K.S. Jagannatha Rao

Related News: NO Laughing Matter—Nitrosylation of Isomerase Spells Trouble for Neurons

Comment by:  sumit gupta
Submitted 10 June 2006 Posted 13 June 2006
  I recommend the Primary Papers

I partially agree with the suggestion that villagers in India who consume mustard oil didn't have AD in old age, also because it was found in current research that turmeric and mustard oil users are less susceptible to AD, but I disagree with his query that we can't relate AD with age as we have certain data for its proof. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. Middle-aged women are at greater risk than men (AD). A recent study shows that high blood pressure dramatically increases this risk, foretelling a potential epidemic of dementia as baby boomers enter their later years. Research at Boston University School of Medicine tracked 4,883 people under evaluation for the Framingham Heart Study. Forty years' worth of data revealed that one in four suffers from AD. Men of the same age are slightly less susceptible, having a one in six chance of AD. Combined, these risk factors threaten one out of every two older women and one in three of their male peers.

I agree with Mr. Ranganath Rao that...  Read more

View all comments by sumit gupta

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2010 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad